Skip to content

Reward Sensitivity and Stress Vulnerability: A pilot study.

Reward Sensitivity and Stress Vulnerability: A pilot study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28401
Enrollment
30
Registered
2013-03-05
Start date
2013-01-05
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reward sensitivity. Stress vulnerability. Healthy volunteers.

Interventions

None listed

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged between 18 – 35; 2. Sufficient command of the Dutch language to understand and give informed consent; 3. Mental competence*; 4. Signed informed consent; 5. Somatically, neurologically and mentally healthy state.

Exclusion criteria

Exclusion criteria: 1. Current Axis I diagnosis of psychiatric disorder or personality disorder; 2. Current alcohol or substance abuse; 3. Current psychotropic medication use.

Design outcomes

Primary

MeasureTime frame
In the reward-learning paradigm, the main study parameter is the performance on the computerized task as measured by percentage correct choices of the rewarding stimulus relative to the losing stimuli. In both the ostracism and the social stress paradigms, the main study parameter is the change in stress scores endorsed by the participants on behavioural questionnaires, as a function of exposure to stressful stimuli. A parallel study parameter is the change in salivary cortisol concentrations as a function of exposure to the stress manipulation.

Secondary

MeasureTime frame
An additional study parameter is the change of stress scores from baseline (baseline) to multiple endpoints (immediately post-study, few hours post-study, the next day, etc) within each individual subject.

Contacts

Public ContactZuzana Kasanova

P.O. Box 616

z.kasanova@maastrichtuniversity.nl+31 (0)43 3883876

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)